Group 1 - The company, Youpin 360 (02360), announced the elevation of its governance committee to an Environmental, Social, and Governance (ESG) Committee, effective December 17, 2025 [1] - The board aims to enhance the company's management standards in environmental, social, and governance aspects, optimizing the governance structure and integrating sustainable development concepts into corporate governance strategies [1] - The responsibilities related to ESG will be added to the existing duties of the governance committee, which will be renamed to reflect this change [1] Group 2 - As of the announcement date, the ESG Committee is chaired by Dr. Gao Wei, with Ms. Cai Suyu and Mr. Lu Rong serving as members [2]

Core Viewpoint - The company, Youpin 360 (02360), has announced the elevation of its governance committee to an Environmental, Social, and Governance (ESG) Committee, effective December 17, 2025, to enhance its management standards and sustainable development capabilities in ESG matters [1] Group 1 - The board of directors has approved the proposal to rename the existing governance committee to the ESG Committee [1] - The responsibilities related to ESG will be added to the current scope of duties, and the committee's authority will be revised accordingly [1] - The changes aim to integrate sustainable development concepts into the company's governance strategy [1] Group 2 - As of the announcement date, the ESG Committee is chaired by Dr. Gao Wei, with members including Ms. Cai Suyu and Mr. Lu Rong [1]

Group 1 - The Environmental, Social, and Governance (ESG) Committee of Shengbo Holdings (02340.HK) has been established and will take effect from December 12, 2025 [1] - The ESG Committee is primarily responsible for reporting to the board regarding the group's practices related to environmental, social, and governance matters [1] - Upon board approval, the committee will also oversee the formulation and implementation of the group's vision, strategies, goals, and policies concerning environmental, social, governance, and climate-related issues [1]

Core Viewpoint - Meiz Health (02415) expects to record a profit attributable to shareholders of no less than RMB 10 million for the six months ending June 30, 2025, compared to a profit of RMB 200,000 for the six months ending June 30, 2024, indicating a significant increase in profitability driven by various factors [1] Group 1: Profit Expectations - The company anticipates a substantial increase in profit, projecting at least RMB 10 million for the upcoming six-month period [1] - In contrast, the profit for the previous comparable period was only RMB 200,000, highlighting a significant year-on-year improvement [1] Group 2: Factors Contributing to Profit Increase - The recovery of the pharmaceutical industry and the accelerated transformation of domestic pharmaceutical companies towards evidence-driven marketing models are driving demand for precise omnichannel marketing solutions [1] - The application of artificial intelligence is enhancing production efficiency across various business segments of the company [1] - The active implementation of environmental, social, and governance (ESG) principles is leading to more effective control of operational costs [1]